A comparison between psilocybin and esketamine in treatment-resistant depression using number needed to treat (NNT): A systematic review (Wong, et al, 2024)

20 abr.

Escrito por Michael DeMarco, therapist

Michael DeMarco, therapist

Psychedelic therapist, clinical sexologist, and Founding Fellow of Psychedelic Institute of Mental Health and Family Therapy

https://psychedelicmentalhealth.net/michael-demarco-therapist

Programa de uso compasivo para la psilocibina posible por primera vez en Alemania

Psilocybin: The Holy Children of the Mazatec people— Columbia School of Social Work (2023)